COVID-19 the anti-viral immune response /

Ligazón do recurso
Series

International biobanking overview of key practices and policies /

Ligazón do recurso
Series

Biobanks and their role in biomedical research

Ligazón do recurso

Ethics and drug development

Ligazón do recurso

Tuberculosis and COVID-19

Ligazón do recurso
Series

SARS-CoV-2 monoclonal antibody testing in vivo

Ligazón do recurso
Series

mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals

Ligazón do recurso
Series

SARS-CoV-2 variants implications for immunity and vaccine development /

Ligazón do recurso
Series

SARS-CoV-2 evolution emergence of the "Californian" and "Indian" variants /

Ligazón do recurso
Series

SARS-COV-2 human monoclonal antibody therapy update

Ligazón do recurso
Series

Emergence of blood clotting disorders resulting from COVID vaccines inoculations

Ligazón do recurso
Series

SARS-CoV-2 evolution within and between individuals

Ligazón do recurso
Series

Identifying SARS-CoV-2 proteases

Ligazón do recurso
Series

Genetic surveillance and the emergence of SARS-CoV-2 variants

Ligazón do recurso
Series

The immune system response to the SARS-CoV-2 virus March 2021 update /

Ligazón do recurso
Series

ABO blood groups and SARS-CoV-2 susceptibility

Ligazón do recurso
Series

Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state

Ligazón do recurso
Series

The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells

Ligazón do recurso
Series

The role of Neuropilin-1 as a SARS-CoV-2-specific endocytosis potentiator

Ligazón do recurso
Series

COVID-19 epidemiology and variants new challenges and future of the pandemic /

Ligazón do recurso
Series